author-photo

Ioannis Sougklakos

5

Papers

46

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Three versus six months adjuvant FOLFOX or CAPOX for high risk stage II and stage III colon cancer patients: The efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant chemotherapy (IDEA) project.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Screening of colorectal cancer (CRC) patients for lynch syndrome (LS) emphasizes the need for public insurance coverage of genetic testing: Results of a national program by the Hellenic Society of Medical Oncology (HeSMO).

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Prospective pooled analysis of four randomized trials investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs 6 months {m}) for patients (pts) with high-risk stage II colorectal cancer (CC).

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (21)